Articles By Nushin Rashidian
Canada’s Securities Regulators Warn Cannabis Industry Over “Conflicts of Interest”
Today, guidance was released for cannabis companies due to the "higher than usual crossover of financial interests" in the industry.
Q&A: Five Questions for Bruce Linton and Kyle Kingsley
Cannabis Wire caught up with the Canopy Growth founder and former CEO on his decision to join Vireo Health as executive chairman.
The Long-Awaited USDA Rules on Hemp Production Have Arrived
Stakeholders are analyzing them as fast as they can, knowing that they may catalyze an already booming industry.
Q&A: Equity in the Spotlight at Gathering of Cannabis Regulators
Colorado regulator Ashley Kilroy tells Cannabis Wire about how equity was top of mind at the 2019 Marijuana Management Symposium in Denver, and about lessons learned from being first.
Q&A: Three Questions for Sanjay Gupta on CBD
On Sunday, CNN will air Gupta’s fifth documentary about cannabis as medicine. Cannabis Wire caught up with Gupta to learn more about his thoughts on the so-called CBD craze and forthcoming FDA regulations.
CannTrust Licenses Suspended, Shopify Enters US, Canopy Ex-CEO’s Next Gigs, & More…
A roundup of the latest major industry moves across the globe.
Scoop: What Did Canopy Growth Say to the White House About USDA Hemp Regs?
Last week, the global cannabis giant gave input on everything from THC testing, to interstate transportation, to seed certification.
Q&A: What Does Silicon Valley’s PAX Have Planned in Canada?
Cannabis Wire spoke with PAX’s first general manager for Canada about new markets, shifting consumer preferences, and the opportunities afforded by federal legalization.
FDA Extends Public Comment on Products Containing Cannabis
The agency, which will determine the future of the CBD industry, also provided an update on its information gathering. And yesterday, Canada’s health officials initiated a somewhat similar process.
